340 related articles for article (PubMed ID: 22469080)
1. Langerhans cells and T cells sense cell dysplasia in oral leukoplakias and oral squamous cell carcinomas--evidence for immunosurveillance.
Öhman J; Magnusson B; Telemo E; Jontell M; Hasséus B
Scand J Immunol; 2012 Jul; 76(1):39-48. PubMed ID: 22469080
[TBL] [Abstract][Full Text] [Related]
2. Presence of CD3-positive T-cells in oral premalignant leukoplakia indicates prevention of cancer transformation.
Öhman J; Mowjood R; Larsson L; Kovacs A; Magnusson B; Kjeller G; Jontell M; Hasseus B
Anticancer Res; 2015 Jan; 35(1):311-7. PubMed ID: 25550565
[TBL] [Abstract][Full Text] [Related]
3. Histological and immunochemical studies of oral leukoplakia: phenotype and distribution of immunocompetent cells.
Bondad-Palmario GG
J Philipp Dent Assoc; 1995; 47(1):3-18. PubMed ID: 9227108
[TBL] [Abstract][Full Text] [Related]
4. A comparative analysis of langerhans cell in oral epithelial dysplasia and oral squamous cell carcinoma using antibody CD-1a.
Upadhyay J; Rao NN; Upadhyay RB
J Cancer Res Ther; 2012; 8(4):591-7. PubMed ID: 23361280
[TBL] [Abstract][Full Text] [Related]
5. [The value of a study of the microvascularization and the cellular immunosurveillance of precancerous states and micro-cancers of the oral cavity].
Chomette G; Auriol M; Labrousse F
Rev Stomatol Chir Maxillofac; 1990; 91(4):262-5. PubMed ID: 1695019
[TBL] [Abstract][Full Text] [Related]
6. Immunosurveillance profile of oral squamous cell carcinoma and oral epithelial dysplasia through dendritic and T-cell analysis.
Pellicioli ACA; Bingle L; Farthing P; Lopes MA; Martins MD; Vargas PA
J Oral Pathol Med; 2017 Nov; 46(10):928-933. PubMed ID: 28585308
[TBL] [Abstract][Full Text] [Related]
7. Langerhans cells in epithelial tumors and benign lesions of the oropharynx.
Girod SC; Kühnast T; Ulrich S; Krueger GR
In Vivo; 1994; 8(4):543-7. PubMed ID: 7893981
[TBL] [Abstract][Full Text] [Related]
8. [Detection of TP53-mutations in brush biopsies from oral leukoplakias].
Scheifele C; Schlechte H; Bethke G; Reichart PA
Mund Kiefer Gesichtschir; 2002 Nov; 6(6):410-4. PubMed ID: 12447653
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of p53 and bcl-2 oncoprotein expression in precancerous lesions of the oral cavity.
Sulkowska M; Famulski W; Chyczewski L; Sulkowski S
Neoplasma; 2001; 48(2):94-8. PubMed ID: 11478700
[TBL] [Abstract][Full Text] [Related]
10. Increased Cyfra 21-1 concentration in saliva from primary oral squamous cell carcinoma patients.
Zhong LP; Zhang CP; Zheng JW; Li J; Chen WT; Zhang ZY
Arch Oral Biol; 2007 Nov; 52(11):1079-87. PubMed ID: 17612501
[TBL] [Abstract][Full Text] [Related]
11. Increased number of CD25 FoxP3 regulatory T cells in oral squamous cell carcinomas detected by chromogenic immunohistochemical double staining.
Schwarz S; Butz M; Morsczeck C; Reichert TE; Driemel O
J Oral Pathol Med; 2008 Sep; 37(8):485-9. PubMed ID: 18355177
[TBL] [Abstract][Full Text] [Related]
12. Changes in peripheral blood lymphocyte phenotypes distribution in patients with oral cancer/oral leukoplakia in Taiwan.
Lee JJ; Lin CL; Chen TH; Kok SH; Chang MC; Jeng JH
Int J Oral Maxillofac Surg; 2010 Aug; 39(8):806-14. PubMed ID: 20605406
[TBL] [Abstract][Full Text] [Related]
13. Carcinoma and dysplasia in oral leukoplakias in Taiwan: prevalence and risk factors.
Lee JJ; Hung HC; Cheng SJ; Chen YJ; Chiang CP; Liu BY; Jeng JH; Chang HH; Kuo YS; Lan WH; Kok SH
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Apr; 101(4):472-80. PubMed ID: 16545712
[TBL] [Abstract][Full Text] [Related]
14. Expression of p16 in oral cancer and premalignant lesions.
Buajeeb W; Poomsawat S; Punyasingh J; Sanguansin S
J Oral Pathol Med; 2009 Jan; 38(1):104-8. PubMed ID: 19192055
[TBL] [Abstract][Full Text] [Related]
15. [Histochemical study of lectin receptor and cell morphometric analysis on oral leukoplakias, epithelial dysplasia and squamous carcinoma].
Jiang Y; Wu Y; Wang F
Zhonghua Kou Qiang Yi Xue Za Zhi; 1996 Nov; 31(6):351-3. PubMed ID: 9592290
[TBL] [Abstract][Full Text] [Related]
16. Role of bcl-2 oncoprotein in oral potentially malignant disorders and squamous cell carcinoma: an immunohistochemical study.
Sudha VM; Hemavathy S
Indian J Dent Res; 2011; 22(4):520-5. PubMed ID: 22124045
[TBL] [Abstract][Full Text] [Related]
17. [The p16 methylation in oral leukoplakia and oral squamous cell carcinoma].
Liu HW; Hu BQ; Cao CF
Zhonghua Kou Qiang Yi Xue Za Zhi; 2005 Mar; 40(2):94-7. PubMed ID: 15842853
[TBL] [Abstract][Full Text] [Related]
18. Decrease in mast cells in oral squamous cell carcinoma: possible failure in the migration of these cells.
Oliveira-Neto HH; Leite AF; Costa NL; Alencar RC; Lara VS; Silva TA; Leles CR; Mendonça FE; Batista AC
Oral Oncol; 2007 May; 43(5):484-90. PubMed ID: 16979374
[TBL] [Abstract][Full Text] [Related]
19. T cells are involved in the induction of macrophage phenotypes in oral leukoplakia and squamous cell carcinoma-a preliminary report.
Stasikowska-Kanicka O; Wągrowska-Danilewicz M; Danilewicz M
J Oral Pathol Med; 2018 Feb; 47(2):136-143. PubMed ID: 29108105
[TBL] [Abstract][Full Text] [Related]
20. Langerhans cells, immunomodulation and skin lesions. A quantitative, morphological and clinical study.
Bergfelt L
Acta Derm Venereol Suppl (Stockh); 1993; 180():1-37. PubMed ID: 7901956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
